Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Portal Hypertension
Under what clinical circumstances do you bypass waiting for a full 48-hour albumin response and start HRS-directed vasoconstrictor therapy earlier because the likelihood of HRS-AKI is high?
Related Questions
How do you use IVC caliber and collapsibility to guide decisions about diuresis?
Who would be the right candidate in which TIPS placement would reduce portal hypertension to allow for a previously unattainable procedure?
What role do you see for albumin infusions in patients with hypoalbuminemia to help assist in volume status, outside of its use in replenishment after a large volume paracentesis or renal dysfunction?
What patient clinical factors do you find most impact a patient's "beta-blocker window" and their ability to maintain and tolerate beta-blocker therapy?
What is your approach to the management of post-TIPS hepatic encephalopathy?
How do you decide between empiric carvedilol versus obtaining HVPG to confirm CSPH when noninvasive markers suggest CSPH but there is limited hemodynamic/renal reserve (borderline MAP and/or CKD)?
What factors do you consider when deciding to treat IgA nephropathy with immunosuppression in a patient with cirrhosis, given the possibility that IgA nephropathy could be secondary to cirrhosis?
How do you decide whether to start vasoconstrictors at 24 hours versus waiting until 48 hours in cirrhosis with suspected HRS-AKI when creatinine has not improved after initial albumin, but the patient is hemodynamically borderline (e.g., low MAP, ongoing diuretics/tense ascites)?
What clinical evidence do you find most favorable of a positive response post-liver transplant for patients with portopulmonary hypertension?
What is your approach to the use of point-of-care ultrasound in the management of a hospitalized patient with decompensated liver disease?
